Study Investigating News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Study Investigating. Real-time updates on events, politics, business and more.

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 RE

May 15, 2024

NEWARK, CA / ACCESSWIRE / May 14, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) (&quot;Protagonist&quot; or the &quot;Company&quot;) today announced that additional data from the rusfertide Phase 2 REVIVE open label extension study will be the focus of an oral presentation at the European Hematology Associatio...

Ann Arbor United States Hall Goya Kristenm Pettit Corey Davis Division Of Hematology Oncology

Source: pharmiweb.com

Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT

August 22, 2022

Focused on developing treatments for rare diseases associated with vascular malformationsRecruited first patients in Proof-of-Concept study for le...

United States United Kingdom Nicholas Benedict Giovanni Mariggi Global Research International Study Investigating

Source: businessinsider.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Study Investigating News Today

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 RE

Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT

Explore More Categories